ReNeuron Group Company
ReNeuron Group engages in R&D and the commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications.
Founded Date:
01.01.1997
Total Funding:
167 333 065
Investor Type:
Company
Employee Number:
51-100
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
Post-IPO Equity
Technology:
Cell Therapy
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
1
Investors Number:
4
Last Funding Date:
10.07.2015
Industry:
Biotechnology
Headquarters:
Guildford, Surrey, United Kingdom
Estimated Revenue:
$1M to $10M